03.09.2010 • News

Airgas and BAE Systems Sign Five-Year Supply Agreement

Airgas today announced it has signed a strategic agreement with BAE Systems, the UK-based defense and aerospace company. Airgas will supply BAE System's manufacturing locations throughout the U.S. with bulk and packaged industrial gas, welding hardgoods and related products and personal protective equipment (PPE) products.

The five-year agreement will be part of the Airgas strategic accounts program which serves multi-location customers who benefit from sole-source supply and supply chain management services.

"Airgas has been providing packaged gases, welding hardgoods and PPE safety products to various BAE Systems locations for a number of years," said Pat Visintainer, Airgas senior vice-president - corporate accounts.

"This agreement strengthens our partnership by extending Airgas supply to all three principal operating groups- electronic intelligence and support, land & armaments, programs and support- with the industrial gases, welding hardgoods and PPE safety products they require," said Annie Van-Vuong, strategic commodity manager, BAE Systems. "Airgas has the national footprint, comprehensive offering, and supply chain management expertise that will help BAE's Systems divisions optimize performance."

Airgas strategic account managers and teams within 12 Airgas regional companies provide day-to-day service through more than 850 branch locations nationwide. The Airgas strategic accounts approach combines the company's industry-leading distribution platform of products and services with professional expertise to deliver custom-tailored solutions for a broad array of industries.

Free Virtual Event

Batteries and Hydrogen: Competitors or Partners?
CHEManager Spotlight

Batteries and Hydrogen: Competitors or Partners?

17 September 2026 | Reserve your spot to learn where solid-state batteries and green hydrogen are headed—and how leading teams are turning them into scalable energy storage solutions.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.